Calcipotriene
Half-Life (t½) TD: 14h
Formula C27H40O3
Molecular Weight 412.62 g/mol
Aliases Calcipotriol, Dovonex Pharmacological Mechanism Topical vitamin D3 analog — VDR agonist on keratinocytes that normalizes hyperproliferation in psoriasis. Often combined with topical corticosteroid (calcipotriene + betamethasone, Taclonex) for synergistic plaque reduction.
Half-Life & Elimination Curve (TD: 14h) 100% 50% 25% 12.5% 0% 0h 0×t½ 14h 1×t½ 28h 2×t½ 42h 3×t½ 56h 4×t½ 70h 5×t½ 0×t½ (0h): 100% remaining 1×t½ (14h): 50% remaining 2×t½ (28h): 25% remaining 3×t½ (42h): 12.5% remaining 4×t½ (56h): 6.3% remaining 5×t½ (70h): 3.1% remaining Elimination (TD)
0×t½ 0h 100% 1×t½ 14h 50% 2×t½ 28h 25% 3×t½ 42h 12.5% 4×t½ 56h 6.3% 5×t½ 70h 3.1% Dosing Guidelines Transdermal (TD): Typical 0.05 mg (Range: 0.05–0.5 mg)Pathways It Modulates Target Organ Systems Endocrine System Integumentary System Chemical Structure & Identifiers InChIKey: LWQQLNNNIPYSNX-UROSTWAQSA-NSMILES: C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)CDirectory Compounds Registry Human Biology Hub